Starting next year, a critical safety net for residents living with HIV and AIDS in Denver just got a five-year funding boost. The City Council has approved a $1.344 million agreement with the Regents of the University of Colorado to sustain and expand the Children's Hospital Immunodeficiency Program's work within the Denver Transitional Grant Area (TGA).
This intergovernmental contract, which runs through February 28, 2031, directs city funds specifically toward care, treatment, and supportive services for vulnerable populations across the entire city. While the TGA designation often focuses on specific zones, this funding ensures that the specialized medical support remains accessible to patients regardless of their neighborhood, addressing a gap in long-term care infrastructure.
The filing, identified as file number 26-1010, moved through the Legislative Analyst Review process and received final approval on July 7, 2026. The agreement underscores a continued municipal commitment to health equity, locking in resources for a program that has long served as a cornerstone for immunodeficiency care in the region. By extending the timeline to 2031, the city provides stability for the UC Regents to maintain staffing and treatment protocols without the disruption of annual re-applications.
Residents interested in the legislative details or upcoming discussions regarding this funding can attend public meetings at Denver City Hall. For specific agenda items and real-time updates on the file, the public can review the official record via the Denver Legistar portal.